A registered PHASE1, PHASE2 study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.
What the source actually supports
- Evidence stage
- Phase 1, Phase 2
- Study design
- RANDOMIZED · PARALLEL · TREATMENT · QUADRUPLE
- Evidence population
- Human clinical study registration
- Participants
- 44
- Population
- ALL · 50 Years
- Duration
- 2016-10-05 to 2017-06-26
- Intervention
- SF0166 Topical Ophthalmic Solution
- Comparator
- Not reported
- Outcomes measured
- Number of Subjects With No Cells Observed Following Slit Lamp Examination From Baseline to Week 8 — Baseline, Week 2, W…; Number of Subjects With Flare Observed Following Slit Lamp Examination From Baseline to Week 8 — Baseline, Week 2, Week…; Number of Subjects With Absence of Hyphema Observed Following Slit Lamp Examination From Baseline to Week 8 — Baseline,…; Number of Subjects With Absence of Bulbar Conjunctival Injection Observed Following Slit Lamp Examination From Baseline…; Number of Subjects With Absence of Erythema Observed Following Slit Lamp Examination From Baseline to Week 8 — Baseline…; Number of Subjects With Absence of Edema Observed Following Slit Lamp Examination From Baseline to Week 8 — Baseline, W…; Number of Subjects With Any Lens Opacity Observed Following Slit Lamp Examination From Baseline to Week 8 — Baseline, W…; Number of Subjects With Abnormal Findings in Optic Nerve Following Fundus Examination From Baseline to Week 8 — Baselin…; Number of Subjects With Abnormal Findings in Vitreous Following Fundus Examination From Baseline to Week 8 — Baseline,…; Number of Subjects With Abnormal Findings in Fundus Following Fundus Examination From Baseline to Week 8 — Baseline, We…; Number of Subjects With Abnormal Findings in Macula/Choroid Following Fundus Examination From Baseline to Week 8 — Base…; Number of Subjects With Abnormal Findings in Vessels Following Fundus Examination From Baseline to Week 8 — Baseline, W…; Cup:Disc Ratio of Subjects Following Fundus Examination From Baseline to Week 8 — Baseline, Week 2, Week 4, Week 6 and…; Number of Subjects With Abnormal Findings Following A Fluorescein Angiogram at Week 4 Compared to Baseline — Baseline a…; Change in Intraocular Pressure From Baseline to Week 8 — Week 2, Week 4, Week 6 and Week 8; Change in Study Eye Central Retinal Thickness (CRT) From Baseline (Day 0) to Week 8 — Week 2, Week 4, Week 6 and Week 8; Change in Best-corrected Visual Acuity (BCVA) From Baseline (Day 0) at Week 4 and Week 8 — Week 2, Week 4, Week 6, and…
- Reported result
- No reusable finding-level result is available in this record.
Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.
Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.
Source supportStructured registry protocol metadata; no finding-level conclusion is generated.
Registration and recruitment status do not establish safety, efficacy, or regulatory approval.
Why this record appears here · 100% topic match
The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.
- Vision ageing · 100%Title contains controlled term: age-related macular degeneration. Abstract contains controlled term: age-related macular degeneration. Source terminology contains: age-related macular degeneration. Title supplies longevity context: age-related. Study type is explicitly identified as INTERVENTIONAL.
Automated source check 100% · update recency 50%. These figures help sort records; they are not medical ratings.